In our latest Trade To Black Podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell continue their weekly Vantage Standard series with Dr. Paul Shields, Chief Medical Officer at Vantage Hemp.This week’s segment tackles a question that continues to come up across healthcare, cannabis, and cannabinoid medicine:Why are so many doctors still hesitant to recommend CBD?The answer may have less to do with the science and more to do with education.Dr. Shields explains why many practicing physicians were never taught about the endocannabinoid system, cannabinoids, or CBD during medical school. As a result, millions of patients are already using CBD products while many healthcare providers are still trying to catch up.The episode also covers the growing Medicare CBD pilot program, the role of FDA guidance, why physician education remains a major hurdle, and what needs to happen before CBD becomes a more widely accepted part of modern healthcare.One statistic that stood out: roughly half of adult patients have tried CBD, while an estimated 10% are actively using it today for issues such as pain, anxiety, sleep, and inflammation.Dr. Shields also shares his thoughts on how healthcare systems responded to GLP-1 medications, what lessons can be learned from past pharmaceutical adoption cycles, and why properly designed clinical data could ultimately determine the future of CBD in medicine.As cannabinoid medicine continues moving closer to the mainstream, physicians, healthcare providers, regulators, and patients are all trying to answer the same question:Log on and leave your comments!00:00:00 – Why Doctors Resist CBD00:01:03 – The CBD Education Gap00:03:21 – FDA Guidance Could Change Everything00:06:33 – Medicine's History of Getting It Wrong00:10:12 – Who Will Educate Physicians on CBD?00:11:50 – The Biggest Risk to the CBD Pilot00:16:18 – CBD as Supplemental Therapy, Not a Cure00:20:40 – The Metrics That Will Determine Success00:22:10 – Building a Scalable CBD Healthcare Model00:23:18 – Why CBD Could Become Mainstream Medicine#CBD #CannabisMedicine #VantageStandard #VantageHemp #CBDResearch #Cannabinoids #HealthcareInnovation #MedicalCannabis #TradeToBlack #FlowhubWant to see more Cannabis Reform?🎬 • Cannabis Stocks Arrive On Robinhood | TDR ... 🎬 • Why Virginia’s Governor Really Vetoed Cann... 🎬 • IRS Tax Guidance Could Boost Cannabis Prof... 🎬 • The Most Important Cannabis Hearing Yet | ... Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook: / thedalesreport ✅ Twitter: / thedalesreport ✅ Instagram: / dalesreport ✅ LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
